GDRX News & Events

GoodRx announced that the new higher dose Novo Nordisk's (NVO) Wegovy HD injection 7.2 mg is now available to eligible self-pay patients on GoodRx at $399 per month. Pricing scales with quantity, with a two-month supply available for $798 and a three-month supply available for $1,197, giving consumers flexibility and clear expectations around cost.

GoodRx (GDRX) announced that it is working with Eli Lilly and Company (LLY) to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo. Eligible self-pay patients can access Foundayo through GoodRx at a starting price of $149 per month, in line with the lowest available discounted cash price at launch. The offering provides transparent pricing and nationwide pharmacy access for the highly anticipated weight management treatment. GoodRx is also expanding access to Zepbound KwikPen, available to eligible self-pay patients starting at $299 per month at more than 70,000 pharmacies nationwide. Together with the launch of Foundayo, these offerings expand access to both oral and injectable GLP-1 treatments for adults seeking prescribed obesity care outside traditional insurance pathways.

In a regulatory filing, the company stated, "On March 24, 2026, Romin Nabiey submitted his resignation as Chief Accounting Officer of GoodRx Holdings, effective April 3, 2026 in order to pursue other opportunities. Nabiey will remain an employee of the company through June 8, 2026 to support the transition of his responsibilities. Nabiey's resignation was not a result of any disagreement between the company and Nabiey on any matter related to the operations, policies, or practices of the company."

GoodRx (GDRX) announced employer-sponsored access to Zepbound KwikPen through GoodRx Employer Direct. As one of Eli Lilly's (LLY) Employer Connect independent program administrators, GoodRx enables self-insured employers to access Zepbound KwikPen at a set price of $449 across all doses, with the flexibility to further subsidize the cost for employees at the pharmacy counter.